A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants

MLA

Judith Falloon, et al. “A Randomized, Double-Blind, Placebo-Controlled, Phase 1/2a Study of the Safety and Immunogenicity of a Live, Attenuated Human Parainfluenza Virus Type 3 Vaccine in Healthy Infants.” Vaccine, vol. 29, no. 40, Apr. 2011. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fe9b73a030ce4030eaab63f923c0eef6&authtype=sso&custid=ns315887.

APA

Judith Falloon, Tingting Yi, & David I. Bernstein. (2011). A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants. Vaccine, 29(40).

Chicago

Judith Falloon, Tingting Yi, and David I. Bernstein. 2011. “A Randomized, Double-Blind, Placebo-Controlled, Phase 1/2a Study of the Safety and Immunogenicity of a Live, Attenuated Human Parainfluenza Virus Type 3 Vaccine in Healthy Infants.” Vaccine 29 (40). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fe9b73a030ce4030eaab63f923c0eef6&authtype=sso&custid=ns315887.